Apolipoprotein E (APOE) (N-Term) Peptide
Aperçu rapide pour Apolipoprotein E (APOE) (N-Term) Peptide (ABIN8094824)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- APOE Peptide - N-terminal region
-
Séquence
- LMDETMKELK AYKSELEEQL TPVAEETRAR LSKELQAAQA RLGADMEDVC
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-APOE Antibody (ARP54284_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- APOE (Apolipoprotein E (APOE))
-
Sujet
-
Background Information: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.
Alternative Symbols: AD2, LDLCQ5, LPG, MGC1571
-
Poids moléculaire
- 34kDa
-
ID gène
- 348
-
NCBI Accession
- NP_000032
-
UniProt
- P02649
Antigène
-